Applied Dna Sciences Inc (NASDAQ:BNBX – Get Free Report) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totaling 116,017 shares, a decrease of 50.0% from the April 30th total of 231,818 shares. Based on an average daily trading volume, of 58,204 shares, the short-interest ratio is presently 2.0 days. Currently, 1.7% of the company’s shares are short sold.
Applied Dna Sciences Price Performance
Shares of BNBX traded up $0.11 during midday trading on Monday, reaching $0.54. 844,281 shares of the stock were exchanged, compared to its average volume of 604,651. Applied Dna Sciences has a 52 week low of $0.35 and a 52 week high of $7.15. The firm has a 50 day moving average price of $0.55. The company has a market capitalization of $3.89 million, a P/E ratio of -0.01 and a beta of 0.52.
Applied Dna Sciences (NASDAQ:BNBX – Get Free Report) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.68) earnings per share for the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%. The company had revenue of $1.02 million for the quarter.
Analysts Set New Price Targets
Check Out Our Latest Research Report on BNBX
Applied Dna Sciences Company Profile
Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.
Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.
Recommended Stories
- Five stocks we like better than Applied Dna Sciences
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
